Education
About Us
Working with TipRanks
Follow Us
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
BIXT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.23
Previous CloseN/A
Volume481.75K
Average Volume (3M)454.81K
Market Cap
$16.43M
Enterprise ValueN/A
Total Cash (Recent Filing)$3.54K
Total Debt (Recent Filing)$95.22K
Price to Earnings (P/E)―
Beta-1.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding88,881,860
10 Day Avg. Volume240,402
30 Day Avg. Volume454,812
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)119.40
P/FCF Ratio97.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Bioxytran News
PremiumCompany Announcements
Bioxytran Delays 10-K Filing Due to Audit
PremiumCompany Announcements
Bioxytran Expands Portfolio with NDPD Pharma Acquisition---
Ownership Overview
33.54% Insiders
―
Mutual Funds
― Other Institutional Investors
66.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIXT FAQ
What was Bioxytran Inc’s price range in the past 12 months?
Bioxytran Inc lowest stock price was $0.06 and its highest was $0.23 in the past 12 months.
What is Bioxytran Inc’s market cap?
Bioxytran Inc’s market cap is $16.43M.
When is Bioxytran Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioxytran Inc’s earnings last quarter?
Currently, no data Available
Is Bioxytran Inc overvalued?
According to Wall Street analysts Bioxytran Inc’s price is currently Overvalued.
Does Bioxytran Inc pay dividends?
Bioxytran Inc does not currently pay dividends.
What is Bioxytran Inc’s EPS estimate?
Bioxytran Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioxytran Inc have?
Bioxytran Inc has 88,881,860 shares outstanding.
What happened to Bioxytran Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bioxytran Inc?
Currently, no hedge funds are holding shares in BIXT
---
Company Description
Bioxytran Inc
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.
---
Technical Analysis
Traws Pharma
―
Affimed
―
BioRestorative Therapies
―
Spruce Biosciences
―
Sensei Biotherapeutics
―
---